Regenxbio RGNX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue (Gross) by Product | ||||||
| Nippon Shinyaku Services | $1.01M-43.0% | $1.4M— | $5.93M— | $2.72M— | $1.77M— | |
| Other Service Revenue | $292K+54.5% | $1.79M+321% | $196K-8.8% | $174K-61.2% | $189K-32.0% | |
| Total Service Revenue | $1.3M-33.6% | $3.19M+649% | $6.13M+2,750% | $2.89M+545% | $1.96M+606% | |
| Zolgensma And Itvisma Royalties | $5.05M-70.3% | —— | —— | —— | $16.99M-16.6% | |
| Revenue by Product | ||||||
| License And Service | $5.09M-94.2% | $27.15M+30.6% | $23.61M-1.6% | $18.47M-15.5% | $87.05M+467% | |
| Service | $1.3M-33.6% | $3.19M+649% | $6.13M+2,750% | $2.89M+545% | $1.96M+606% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Regenxbio break its business down?
- Regenxbio (RGNX) reports revenue (gross) by product across 4 parts — Nippon Shinyaku Services, Other Service Revenue, Total Service Revenue and Zolgensma And Itvisma Royalties. Each is extracted from the segment footnotes and tracked over time.
- Where does Regenxbio's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Regenxbio's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
